The production of ELISA test systems for the assessment of acute conditions of DIA®-CRP and DIA®-D-dimer, for the quantitative determination of the concentration of D-dimer and C reactive protein in human plasma and serum, respectively, was put into circulation and resumed.
Providing our customers with quality diagnostics in a COVID-19 pandemic is the main goal of the Diaprof-Med team. Guided by this principle and at the request of many consumers, the production of ELISA test systems for the assessment of acute conditions DIA®-CRP and DIA®-D-dimer was introduced and resumed, which is especially important for differential diagnosis of COVID-19 and assessment of the level and prognosis of risks. complications. Test systems are developed on the principle of solid-phase ELISA in the "sandwich" format. The test system contains calibrators for constructing a calibration curve and calculating the analyte concentration.
More information about the tests